medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2011, Number 03

<< Back Next >>

Ginecol Obstet Mex 2011; 79 (03)

Trombosis arterial en el síndrome de hiperestimulación ovárica

García-Benítez CQ, Avilés-Cabrera RN

Language: Spanish
References: 10
Page: 152-155
PDF size: 231.30 Kb.


ABSTRACT

Ovarian hyperstimulation syndrome is an iatrogenic complication of controlled ovarian hyperstimulation. Its features are excessive growth of the ovaries and leakage of fluid from the intravascular space with ascites, hypovolemia and electrolyte imbalance, inducing a state of hypercoagulability, which can cause arterial or venous thrombosis. Thromboembolic events are the less common complications but they are the most serious. We communicate the case of a 30 years old woman with history of primary infertility; she was in treatment with controlled ovarian hyperstimulation. The patient developed ovarian hyperstimulation syndrome and arterial thrombosis in the right femoral artery.


REFERENCES

  1. Horwitz J, Pundi R, Blankstein J. Ovarian hyperstimulation syndrome. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2008.

  2. Insler V, Lunenfield B. Pathogenesis of ovarian hyperstimulation syndrome. En: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2008.

  3. Insler V, Lunenfield B. Classification and treatment of ovarian hyperstimulation syndrome. En: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2008.

  4. Justice H, Counselman F. Ovarian hyperstimulation syndrome. An important complication of in vitro fertilization. Am J Em Med 2008;26:115.e3-115.e4.

  5. Miller MA. An unusual cause of tachycardia, hypotension, and intraabdominal free fluid: ovarian hyperstimulation syndrome. Am J Em Med 2008;26:736.e3-736.e4.

  6. Kably A, Ruiz J, Sánchez A. Tratamiento del síndrome de hiperestimulación ovárica grave mediante paracentesis descompresiva y autotransfusión de líquido de ascitis. Ginecol Obstet Mex 2006;74:291-299.

  7. Aboulghar M, Mansour R, Serour G, Sattar M, et al. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet Gynecol 1993;81:108-111.

  8. Aurousseau MH, Samama MM, Belhassen A, et al. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod 1995;10:94-97.

  9. Baumann P, Diedrich K. Thromboembolic Complications associated with reproductive endocrinologic procedures. Hematol Oncol Clin N Am 2000;14(2):431-443.

  10. Girolami A, Scandellari R, Tezza F, Paternoster D, Girolami B. Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis 2007;24:169-174.




2020     |     www.medigraphic.com